These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 13719415)

  • 1. Studies on headache. The mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    DALESSIO DJ; CAMP WA; GOODELL H; WOLFF HG
    Arch Neurol; 1961 Mar; 4():235-40. PubMed ID: 13719415
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies in headache: further analysis of the mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    DALESSIO DJ; CAMP WA; GOODELL H; WOLFF HG
    Trans Am Neurol Assoc; 1961; 86():95-8. PubMed ID: 13883198
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
    FRIEDMAN AP; LOSIN S
    Arch Neurol; 1961 Mar; 4():241-5. PubMed ID: 13701987
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylaxis of frequent vascular headache with methysergide.
    HALE AR; REED AF
    Am J Med Sci; 1962 Jan; 243():92-8. PubMed ID: 13903795
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
    FRIEDMAN AP
    Angiology; 1960 Aug; 11():364-6. PubMed ID: 13825096
    [No Abstract]   [Full Text] [Related]  

  • 6. THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
    CROWTHER DL
    Med Exp Int J Exp Med; 1964; 10():137-43. PubMed ID: 14129849
    [No Abstract]   [Full Text] [Related]  

  • 7. CENTRAL MECHANISMS IN HEADACHE.
    DALESSIO DJ
    Headache; 1965 Jan; 5():276-8. PubMed ID: 14264176
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on headache. The responses of the bulbar conjunctival blood vessels during induced oliguria and diuresis, and their modification by UML-491.
    DALESSIO DJ; CHAPMAN LF; ZILELI T; CATTELL M; EHRLICH R; FORTUIN F; GOODELL H; WOLFF HG
    Arch Neurol; 1961 Dec; 5():590-3. PubMed ID: 13883199
    [No Abstract]   [Full Text] [Related]  

  • 9. Appraisal of methysergide in treatment of vascular headaches of migraine type.
    FRIEDMAN AP; ELKIND AH
    JAMA; 1963 Apr; 184():125-8. PubMed ID: 13959785
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and rheographic considerations on a new antiserotonin derivative (UML-491) with preventive action in hemicrania].
    REBUCCI GG; COCCAGNA G
    Riv Neurol; 1962; 32():574-85. PubMed ID: 13973457
    [No Abstract]   [Full Text] [Related]  

  • 11. Vasodilating headache: a suggested classification and results of prophylactic treatment with UML 491 (methysergide).
    ROOKE ED; RUSHTON JG; PETERS GA
    Proc Staff Meet Mayo Clin; 1962 Aug; 37():433-43. PubMed ID: 14493709
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of antiepileptic properties of a lysergic-acid-derivative-UML 491-serotonin antagonist; preliminary report.
    SICUTERI F
    Med Exp Int J Exp Med; 1960; 2():36-9. PubMed ID: 14446407
    [No Abstract]   [Full Text] [Related]  

  • 13. The serotonin antagonist 1-methyl-D-lysergic acid butanolamine (UML-491) or methysergide ('Deseril'), its pharmacodynamics and effects on 'migraine type' vascular headaches.
    LEIGH WE
    S Afr Med J; 1963 Jun; 37():631-7. PubMed ID: 13929429
    [No Abstract]   [Full Text] [Related]  

  • 14. An evaluation of methysergide in the prevention of migraine and other vascular headaches.
    LANCE JW; FINE RD; CURRAN DA
    Med J Aust; 1963 Jun; 50(1)():814-8. PubMed ID: 13928400
    [No Abstract]   [Full Text] [Related]  

  • 15. A new approach to the prophylactic treatment of vascular headache.
    HARRIS MC
    Allerg Asthma (Leipz); 1961 Sep; 7():287-92. PubMed ID: 13904856
    [No Abstract]   [Full Text] [Related]  

  • 16. [TREATMENT OF MIGRAINE AND ERYTHROPROSOPALGIA WITH METHYSERGIDE].
    HEYCK H
    Munch Med Wochenschr; 1964 Nov; 106():2213-9. PubMed ID: 14315954
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.
    GRAHAM JR
    N Engl J Med; 1960 Dec; 263():1273-7. PubMed ID: 13707731
    [No Abstract]   [Full Text] [Related]  

  • 18. Headache. Pharmacological approach to treatment.
    FRIEDMAN AP
    Calif Med; 1961 Sep; 95(3):145-9. PubMed ID: 13701988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLINICAL STUDIES ON THE TREATMENT OF VASCULAR HEADACHES, A PROGRESS REPORT ON METHYSERGIDE (SANSERT).
    ABBOTT KH
    Headache; 1965 Jan; 5():261-71. PubMed ID: 14264174
    [No Abstract]   [Full Text] [Related]  

  • 20. [First experiments in hemicrania and epilepsy with 1-methyl-lysergic acid butanolamide, a substance with antiserotonin effects].
    SICUTERI F
    Prog Med (Napoli); 1960 Jan; 16():20-2. PubMed ID: 14446409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.